APA (7th ed.) Citation

AM, G., M, D., N, C., V, O., N, S., D, F., . . . SM, R. (2021). Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma. Life sciences, 268, 118979. https://doi.org/10.1016/j.lfs.2020.118979

Chicago Style (17th ed.) Citation

AM, Gamboa-Cedeño, et al. "Apoptotic Regulator BCL-2 Blockade as a Potential Therapy in Classical Hodgkin Lymphoma." Life Sciences 268 (2021): 118979. https://doi.org/10.1016/j.lfs.2020.118979.

MLA (9th ed.) Citation

AM, Gamboa-Cedeño, et al. "Apoptotic Regulator BCL-2 Blockade as a Potential Therapy in Classical Hodgkin Lymphoma." Life Sciences, vol. 268, 2021, p. 118979, https://doi.org/10.1016/j.lfs.2020.118979.